Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayFeb 15, 2017 11:45 am

Safeguard Scientifics (NYSE: SFE) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Safeguard Scientifics (NYSE: SFE) provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. The company targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the Internet of Everything, enhanced security and predictive analytics. Safeguard typically deploys between $5 million and $25 million over the course of its partnership with a company, initially investing in a Series A or B Round and opportunistically in a Seed Round. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more…

Continue Reading

WednesdayFeb 15, 2017 11:45 am

Immune Pharmaceuticals, Inc. (NASDQ: IMNP) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Immune Pharmaceuticals (NASDAQ: IMNP) is focused on developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, bertilimumab, is in phase II clinical development for moderate-to-severe ulcerative colitis as well as for bullous pemphigoid, an orphan autoimmune dermatological condition. Other indications being considered for development include atopic dermatitis, Crohn's disease, severe asthma and Non-Alcoholic Steato-Hepatitis (NASH), an inflammatory liver disease. Immune’s portfolio in immuno-dermatology includes a treatment for psoriasis and atopic dermatitis. Its oncology pipeline includes Ceplene® for maintenance remission in Acute Myeloid Leukemia (AML) in combination with…

Continue Reading

WednesdayFeb 15, 2017 11:30 am

ORHub, Inc. (ORHB) is “One to Watch”

ORHub, Inc. (OTC: ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another. The need for ORHub is clear. Health care costs are out of control at more than 17% of US…

Continue Reading

WednesdayFeb 15, 2017 11:15 am

MTBC (NASDAQ: MTBC) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

MTBC (NASDAQ: MTBC) is a health care information technology company that provides a fully integrated suite of proprietary web-based and mobile health solutions, together with related business services, to healthcare providers throughout the United States. The company’s integrated SaaS platform helps its customers increase revenues, streamline workflows, and make better business and clinical decisions, while reducing administrative burdens and operating costs. For more information, visit the company’s website at www.mtbc.com About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with…

Continue Reading

WednesdayFeb 15, 2017 11:15 am

Delcath Systems (NASDAQ: DCTH) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Delcath Systems (NASDAQ: DCTH) operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. For more information, visit the company's website at www.delcath.com. About NetworkNewsWire NetworkNewsWire…

Continue Reading

WednesdayFeb 15, 2017 11:15 am

Cytori Therapeutics (NASDAQ: CYTX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Cytori Therapeutics (NASDAQ: CYTX) develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy. For more information, visit the company's website at www.cytori.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

Continue Reading

WednesdayFeb 15, 2017 10:45 am

Cemtrex, Inc. (NASDAQ:CETX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Cemtrex (NASDAQ:CETX) is a diversified industrial and manufacturing company that provides a wide array of solutions to meet today's technology challenges. Cemtrex provides manufacturing services of advanced custom engineered electronics, industrial services, monitoring instruments for industrial processes and environmental compliance, and systems for controlling particulates, hazardous gases, emissions of Greenhouse gases, and other regulated pollutants used in emissions trading globally. For more information, visit the company’s website at www.cemtrex.com About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an…

Continue Reading

WednesdayFeb 15, 2017 10:45 am

NABUFIT Global, Inc. (NBFT) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

NABUFIT Global (OTCQB: NBFT) is an online fitness platform for health and well-being through physical exercises, nutrition and lifestyle. The platform offers an interactive, customized experience founded on the workouts and participation of Sports Stars, including Neymar Jr., Mo Farah, Peter Schmeichel, Michael Maze, and many more to come. The development, headquartered in Denmark, is developing an online fitness platform and a mobile application that connects to existing and future monitoring devices such as wearables. For more information, visit the company’s website at: www.nabufit.com About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

Continue Reading

WednesdayFeb 15, 2017 10:45 am

IntelliPharmaCeutics International (NASDAQ: IPCI) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

IntelliPharmaCeutics International (NASDAQ: IPCI) is a pharmaceutical company that engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The company develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in various stages of development in therapeutic areas, such as neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. Its lead product is Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for attention deficit hyperactivity disorders. For more information, visit the company's website at www.intellipharmaceutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release…

Continue Reading

WednesdayFeb 15, 2017 10:00 am

Lantronix (NASDAQ: LTRX) Starts Presentation at 2017 Disruptive Growth & Healthcare Conference

Lantronix (NASDAQ: LTRX) is a specialized networking company providing smart Internet of Things (IoT) and machine-to-machine (M2M) solutions. The company's innovative products deliver secure connectivity, device management, and mobility for today's increasingly connected world. By networking and managing devices and machines that have never before been connected, Lantronix's connectivity solutions are deployed inside millions of machines serving a wide range of industries, including data center, medical, security, industrial, transportation, retail, financial, environmental and government. For more information, visit the company's website at www.lantronix.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000